Charity workshop set to unlock new treatments for Parkinson’s
Parkinson’s UK has held its first ever Drug Discovery Workshop in an effort to unlock new treatments by seeking new ways to progress...
Keapstone Board of Directors meeting
Keapstone Therapeutics, the single-asset virtual biotech created by University of Sheffield with funding from Parkinson’s UK, held a...
Keapstone Therapeutics launched in world-first partnership to develop new drugs for Parkinson’s
The University of Sheffield and Parkinson’s UK have launched a new £1million virtual biotech company in the next stage[1] of a pioneering...
Parkinson's UK & MedGenesis Therapeutix Inc. announce top-line results of Phase 2 GDNF safet
Parkinson's UK and MedGenesis Therapeutix Inc. announced today that the Phase 2 clinical trial evaluating the safety and efficacy of...